Unknown

Dataset Information

0

The Groebke-Blackburn-Bienayme Reaction.


ABSTRACT: Imidazo[1,2-a]pyridine is a well-known scaffold in many marketed drugs, such as Zolpidem, Minodronic acid, Miroprofen and DS-1 and it also serves as a broadly applied pharmacophore in drug discovery. The scaffold revoked a wave of interest when Groebke, Blackburn and Bienaymé reported independently a new three component reaction resulting in compounds with the imidazo[1,2-a]-heterocycles as a core structure. During the course of two decades the Groebke Blackburn Bienaymé (GBB-3CR) reaction has emerged as a very important multicomponent reaction (MCR), resulting in over a hundred patents and a great number of publications in various fields of interest. Now two compounds derived from GBB-3CR chemistry received FDA approval. To celebrate the first 20 years of GBB-chemistry, we present an overview of the chemistry of the GBB-3CR, including an analysis of each of the three starting material classes, solvents and catalysts. Additionally, a list of patents and their applications and a more in-depth summary of the biological targets that were addressed, including structural biology analysis, is given.

SUBMITTER: Boltjes A 

PROVIDER: S-EPMC8130801 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3448811 | biostudies-literature
| S-EPMC9300155 | biostudies-literature
| S-EPMC10241102 | biostudies-literature
| S-EPMC9496245 | biostudies-literature
| S-EPMC6045402 | biostudies-literature
| PRJNA280654 | ENA
| S-EPMC3229210 | biostudies-literature
2013-11-14 | E-GEOD-52341 | biostudies-arrayexpress
2023-11-14 | GSE247565 | GEO
2016-12-14 | GSE81850 | GEO